CTLA4 and Hepatic fibrosis: Under an increased tumour burden (1 × 106 implanted cells), where parallel tumour growth was induced in both groups, mice with CCl4‐induced advanced liver fibrosis showed both a delayed and weakened anti‐tumour response upon treatment with anti‐PD‐1 and anti‐CTLA‐4 immunotherapy (Figure 5C).